vktx stock forecast zacks

Learn more on VKTXs analyst rating. Rooms Shows Rankings Earnings Newsletters Shop.

3 Strong Buy Biotech Stocks Trading Under 10

On average they anticipate Viking Therapeutics stock price to reach 1550 in the next year.

. VKTX announced that an abstract describing additional data from the Phase 2 trial of VK2809 in patients with non-alcoholic fatty liver disease NAFLD and hypercholesterolemia was selected. Stock news by MarketWatch. The company generates around 95 billion in annual revenues and produces in excess of three million barrels per day of oil equivalent.

By David Bautz PhD NASDAQVKTX READ THE FULL VKTX RESEARCH REPORT Business Update Management Provides Update on 2021 Outlook We recently spoke to the management team at Viking Therapeutics Inc. A B is better than a C. Real-time trade and investing ideas on Viking Therapeutics Inc VKTX from the largest community of traders and investors.

Brokerages expect that Viking Therapeutics Inc. 5 months ago -. Find the latest Viking Therapeutics Inc.

By David Bautz PhD VKTX READ THE FULL VKTXV RESEARCH REPORT Business Update Podium Presentation at EASL On February 26 2020 Viking Therapeutics Inc. VKTX have gained 05 over the past four weeks to close the last trading session at 573 but there could still be. According to the issued ratings of 7 analysts in the last year the consensus rating for Viking Therapeutics stock is Buy based on the current 7 buy ratings for VKTX.

A C is better than a D. Hedge funds were also right about betting on VKTX as the stock returned 153 since the. 2022 at 1103 am.

Since 1988 it has more than doubled the SP 500 with an average gain of. These stocks gained 307 in 2020 through December 14th and still beat the market by 158 percentage points. Wall Street Stock Market Finance report prediction for the future.

Youll find the Viking Therapeutics share forecasts stock quote and buy sell signals belowAccording to present data Viking Therapeuticss VKTX shares and potentially its market environment have been in bearish. As an investor you want to. View analysts price targets for Viking Therapeutics or view top-rated stocks among Wall Street analysts.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Buy or sell Viking Therapeutics stock. In addition the company is continuing to open additional sites both in the US.

Shares have declined slightly more than 3 since. The Viking Therapeutics stock price gained 250 on the last trading day Monday 25th Apr 2022 rising from 240 to 246. Explore Investment Resources Portfolios Market Commentary More at Zacks.

Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that nearly triples the SP 500. And a D is better than an F. The consensus price target hints at a 2041 upside potential for Viking Therapeutics Inc.

NASDAQVKTX Get Rating will post earnings of 021 per share for the current quarter according to Zacks Investment Research. The price has fallen in 6 of the last 10 days and is down by -1517 for this period. Viking Therapeutics Inc 251 002 079 Watch.

VKTX has been on a downward spiral lately with significant selling pressure. The average twelve-month price target for Viking Therapeutics is 1543 with a high price target of 2100 and a low price target of 1000. Viking is currently conducting a Phase 1 clinical trial of VK0214 in.

This suggests a possible upside of 4657 from the stocks current price. Wall Street Analysts Think 204. The current Viking Therapeutics Inc VKTX share price is 253.

An A is better than a B. Four analysts surveyed by Zacks expected 536 billionCorteva Inc. The Score for VKTX is 53 which is 6 above its historic median score of 50 and infers lower risk than normal.

NASDAQVKTX including CEO Brian Lian regarding the outlook for the company in 2021 and anticipated milestones regarding the. VKTX is currently trading in the 50-60 percentile range relative to its historical Stock Score levels. View real-time stock prices and stock quotes for a full financial overview.

2 days agoWall Street brokerages expect Viking Therapeutics Inc. Shares of Viking Therapeutics Inc. 1 Wall Street analyst that have issued a 1 year VKTX price target the average VKTX price target is 1000 with the highest VKTX stock price forecast at 1000 and the lowest VKTX stock price forecast at 1000.

Chevron currently churns out oil and natural gas at a 5941. Viking continues to anticipate enrollment completing in the first half of 2021 which could lead to 12-week liver fat data being available by the end of 2021 or early 2022. Ad Find Top Rated Stocks Information to Help You Beat the Market.

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 120 per shareThe agriculture posted revenue of 519 billion in the period falling short of Street forecasts. Their forecasts range from 1000 to 2100. NASDAQVKTX Get Rating to post earnings per share of 021 for the current quarter according to Zacks Investment Research.

After declining 248 over the past four weeks the stock looks well positioned for a trend. While empirical research shows that this sought-after metric is hardly effective an upward trend in e. During the day the stock fluctuated 380 from a day low at 237 to a day high of 246.

Viking Therapeutics Inc Stock Market info Recommendations. VKTX stock quote history news and other vital information to help you with your stock trading and investing. Viking Therapeutics Inc.

Volume fell on the last day by -330 thousand. VKTX Complete Viking Therapeutics Inc. Find real-time VKTX - Viking Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.

Ehbcppngoet11m